- Report
- February 2024
- 115 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- April 2023
- 114 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- April 2023
- 100 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- April 2023
- 120 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- February 2024
- 115 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- August 2024
- 110 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- November 2023
- 146 Pages
Global
From €3129EUR$3,560USD£2,707GBP
€3911EUR$4,450USD£3,383GBP
- Report
- February 2023
- 118 Pages
From €3032EUR$3,450USD£2,623GBP
- Report
- February 2023
- 107 Pages
Africa, Middle East
From €3032EUR$3,450USD£2,623GBP
- Report
- February 2023
- 126 Pages
Europe
From €3032EUR$3,450USD£2,623GBP
- Report
- December 2022
- 190 Pages
Global
From €3911EUR$4,450USD£3,383GBP
- Report
- February 2024
- 150 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- June 2024
- 183 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- June 2025
- 250 Pages
Japan
From €2451EUR$2,789USD£2,120GBP
- Report
- April 2023
- 147 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- June 2025
- 250 Pages
India
From €2451EUR$2,789USD£2,120GBP
- Report
- August 2024
- 200 Pages
Global
From €3401EUR$3,869USD£2,942GBP
- Report
- December 2023
- 160 Pages
United States
From €2451EUR$2,789USD£2,120GBP
- Report
- May 2023
- 147 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- March 2023
- 107 Pages
Global
From €3163EUR$3,599USD£2,736GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more